Experts from Columbia University highlight approvals in CLL, bispecific antibodies in multiple myeloma, and actionable biomarkers in DLBCL.
Hua-Jay J Cherng, MD
Advertisement
Articles by Hua-Jay J Cherng, MD
Advertisement
Latest Updated Articles
Insights Across Hematologic Oncology at Columbia UniversityMarch 16th 2026
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
2
What is The State of Radiation Oncology in Head and Neck Cancers?
3
Elranatamab Significantly Improves PFS in R/R Multiple Myeloma Trial
4
Combining a PCNA Inhibitor with KRAS-Targeting Agents in PDAC
5